Paper39487553
Ribosomal proteins in hepatocellular carcinoma: mysterious but promising.
Su Q and 6 others. Cell Biosci, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Ribosomal proteins in hepatocellular carcinoma: mysterious but promising. Papers, record 39487553. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39487553
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No.7232142 | Natural Science Foundation of Beijing Municipality | PubMed | ||
| No. 82202612 | National Natural Science Foundation of China | PubMed |
Source PubMed
References153
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33987350 | Immune checkpoint inhibitor plus tyrosine kinase inhibitor for unresectable hepatocellular carcinoma in the real world. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/33987350 | PubMed |
| 2 | 32395510 | High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection. | Ann Transl Med | 2020 | https://conductscience.org/library/papers/32395510 | PubMed |
| 3 | 36684217 | Classification of the mitochondrial ribosomal protein-associated molecular subtypes and identified a serological diagnostic biomarker in hepatocellular carcinoma. | Front Surg | 2022 | https://conductscience.org/library/papers/36684217 | PubMed |
| 4 | 28161490 | Structural analysis of ribosomal RACK1 and its role in translational control. | Cell Signal | 2017 | https://conductscience.org/library/papers/28161490 | PubMed |
| 5 | 29344114 | HNF-4α promotes multidrug resistance of gastric cancer cells through the modulation of cell apoptosis. | Oncol Lett | 2017 | https://conductscience.org/library/papers/29344114 | PubMed |
| 6 | 32316188 | Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2. | Cells | 2020 | https://conductscience.org/library/papers/32316188 | PubMed |
| 7 | 26030272 | Mitochondrial ribosome assembly in health and disease. | Cell Cycle | 2015 | https://conductscience.org/library/papers/26030272 | PubMed |
| 8 | 24099156 | Transcriptional regulation by hypoxia inducible factors. | Crit Rev Biochem Mol Biol | 2014 | https://conductscience.org/library/papers/24099156 | PubMed |
| 9 | 37446035 | Cisplatin in Liver Cancer Therapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446035 | PubMed |
| 10 | 16728594 | p53 regulates mitochondrial respiration. | Science | 2006 | https://conductscience.org/library/papers/16728594 | PubMed |
| 11 | 17881366 | Human ribosomal protein S13 regulates expression of its own gene at the splicing step by a feedback mechanism. | Nucleic Acids Res | 2007 | https://conductscience.org/library/papers/17881366 | PubMed |
| 12 | 36577883 | Silencing RPL8 inhibits the progression of hepatocellular carcinoma by down-regulating the mTORC1 signalling pathway. | Hum Cell | 2023 | https://conductscience.org/library/papers/36577883 | PubMed |
| 13 | 36152386 | The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022. | Eur J Med Chem | 2022 | https://conductscience.org/library/papers/36152386 | PubMed |
| 14 | 31886121 | The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma. | Anal Cell Pathol (Amst) | 2019 | https://conductscience.org/library/papers/31886121 | PubMed |
| 15 | 36549921 | GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. | Brief Bioinform | 2023 | https://conductscience.org/library/papers/36549921 | PubMed |
| 16 | 32627011 | Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis. | Oncol Rep | 2020 | https://conductscience.org/library/papers/32627011 | PubMed |
| 17 | 12368239 | Identification and analysis of over 2000 ribosomal protein pseudogenes in the human genome. | Genome Res | 2002 | https://conductscience.org/library/papers/12368239 | PubMed |
| 18 | 21857917 | RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function. | PLoS One | 2011 | https://conductscience.org/library/papers/21857917 | PubMed |
| 19 | 12872448 | Phase II study to topotecan and cisplatin in advanced hepatocellular carcinoma. | Korean J Intern Med | 2003 | https://conductscience.org/library/papers/12872448 | PubMed |
| 20 | 9858605 | Ribosomal protein S14 of Saccharomyces cerevisiae regulates its expression by binding to RPS14B pre-mRNA and to 18S rRNA. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/9858605 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41977283 | SLC25A39 Upregulation Is Associated with DNA Methylation, Immune Cell Infiltration, and Poor Prognosis in Hepatocellular Carcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977283 | PubMed |
| 41777648 | RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression. | Front Oncol | 2026 | https://conductscience.org/library/papers/41777648 | PubMed |
| 40862733 | Interpretation of the Transcriptome-Based Signature of Tumor-Initiating Cells, the Core of Cancer Development, and the Construction of a Machine Learning-Based Classifier. | Cells | 2025 | https://conductscience.org/library/papers/40862733 | PubMed |
| 40792132 | TSPAN9 inhibits malignant progression of hepatocellular carcinoma. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/40792132 | PubMed |
| 40715829 | The role of mitochondria-related genes in hepatocellular carcinoma prognosis: construction of prognostic models based on machine learning. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40715829 | PubMed |
| 40715580 | The role of glucocorticoids in hepatocellular carcinoma through integrated bioinformatics analysis and experimental validation. | Sci Rep | 2025 | https://conductscience.org/library/papers/40715580 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39487553
GET https://conductscience.org/api/papers/v1/39487553/references?page=2